VANCOUVER, BC – Kapoose Creek Bio, a Vancouver-based biotechnology company leveraging AI for drug discovery from nature, announced the identification and advancement of two lead compounds with exciting potential in neurology, spanning… Read More
VANCOUVER, BC — Kardium Inc., a private medical device company that has developed the Globe® System for the treatment of atrial fibrillation (AF), announced positive results of the 1-year outcomes of the… Read More
Under a new agreement, GlycoNet and NOVA FCT will leverage their combined expertise in the study of carbohydrates for knowledge exchange, collaborative research and training opportunities. EDMONTON, AB – GlycoNet, one of the world’s leaders in glycomics, has signed a… Read More
Prince George celebrated a significant milestone in early 2024 with the opening of a new clinical trial called CIRCULATE-NORTH-AMERICA, or CRC10, which marked the first time a systemic therapy clinical… Read More
Montreal, QC — Amplitude Ventures, a full-stack venture capital firm focused on investing in precision medicine at the intersection of biology and AI, announced the close of its $263 million… Read More
